Nanobody-mediated Complement Activation to Kill HIV-infected Cells
M. L. Pedersen, D. V. Pedersen, M. B. L. Winkler, H. G. Olesen, O. S. Sogaard, L. Ostergaard, N. S. Laursen, A. H. F. Andersen, M. Tolstrup
This paper develops a bispecific complement engager to target HIV-1-infected cells, enhancing complement-mediated killing through C3 deposition and CDC.
bioRxiv · Jun 9, 2022Immunology